Notes

A Look At The Ugly The Truth About ADHD Medication Pregnancy
ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during breastfeeding and pregnancy is challenging for women with the condition. There is a lack of information about how long-term exposure to these medications may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it against the potential dangers for the foetus. Physicians don't have the data to provide clear recommendations but they can provide information about risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy were not at a higher risk of fetal malformations, or structural birth defects. The researchers used a large, population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants during early pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to confirm that the classification was correct and to reduce any bias.

However, the study had its limitations. The most important issue was that they were unable to distinguish the effects of the medication from those of the underlying disorder. That limitation makes it difficult to know whether the small differences observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. Researchers also did not study long-term outcomes for offspring.

The study showed that infants whose mother had taken ADHD medication during pregnancy were at a slightly higher risk of admission to the neonatal care unit (NICU), compared to those whose mothers did not take any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an elevated risk of having a caesarean delivery or having a baby born with low Apgar score (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefit for both mother and child of continued treatment for the woman's condition. Physicians should talk to their patients about this issue and as much as possible, assist them develop coping strategies that could reduce the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the issue of whether to continue or stop treatment during pregnancy is a question that more and more physicians confront. Often, these decisions are made without any evidence that is clear and definitive either way, so physicians have to weigh their experience about their experiences, the experiences of other doctors, and what the research suggests about the subject and their best judgment for each individual patient.

The issue of possible risks to infants is difficult to determine. Many of the studies on this issue are based on observational data rather than controlled research and their conclusions are often contradictory. Furthermore, most studies restrict their analysis to live births, which can underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by examining data on both live and deceased births.

The conclusion is that while some studies have found an association between ADHD medications and the risk of certain birth defects, others have not found any evidence of a link, and most studies have a neutral or slightly negative impact. In each case an in-depth evaluation of the potential risks and benefits should be conducted.

For many women with ADHD and ADD, the decision to discontinue medication can be difficult, if not impossible. In adult adhd medication published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. Additionally, the loss of medication can affect the ability to perform work-related tasks and safely drive that are crucial aspects of a normal life for many people with ADHD.


She suggests that women who are unsure whether to continue taking medication or discontinue it due to pregnancy should educate family members, coworkers and friends about the condition, its effects on daily functioning, and the advantages of staying on the current treatment plan. It can also help women feel more confident in her decision. It is important to note that certain medications can pass through the placenta so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the drug can be transferred to the infant.

Risk of Birth Defects

As the use and use of ADHD medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing as does the concern about the potential effects of these drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the existing information on this topic. Researchers used two huge data sets to study more than 4.3 million pregnant women and determine if the use of stimulant medications increased birth defects. Although the risk overall remains low, the researchers did find that first-trimester exposure to ADHD medications was associated with an increase in the risk of certain heart defects such as ventriculo-septal defect (VSD).

The researchers of the study could not discover any link between early medication usage and other congenital anomalies like facial deformities, or club feet. The results are consistent with previous studies revealing a small but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications before pregnancy. This risk increased during the latter part of pregnancy when a large number of women stopped taking their medication.

Women who used ADHD medication in the first trimester of pregnancy were also more likely to have a caesarean section, a low Apgar score following delivery, and a baby who required breathing assistance during birth. However the researchers of the study were not able to eliminate bias due to selection by limiting the study to women who didn't have any other medical issues that could be a contributing factor to these findings.

Researchers hope that their study will help doctors when they encounter pregnant women. They recommend that, while discussing the risks and benefits is crucial but the decision to stop or maintain treatment must be based on each woman's requirements and the severity of her ADHD symptoms.

add adhd medication that even though stopping the medication is an option, it is not a recommended practice because of the high prevalence of depression and other mental health issues in women who are pregnant or postpartum. Research has also shown that women who stop taking their medications will have a difficult adjustment to life without them once the baby is born.

Nursing

The responsibilities of a new mom can be overwhelming. Women who suffer from ADHD who must work through their symptoms while attending physician appointments as well as preparing for the arrival of their child and getting used to new routines at home are often faced with a number of difficulties. As such, many women elect to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medicines pass through breast milk in small quantities, so the risk to nursing infant is very low. However, the amount of exposure to medication by the newborn can vary depending on the dosage, frequency it is taken and the time of day it is administered. Additionally, different medications enter the baby's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn is not well understood.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the lack of research. This is a complicated decision for the patient, who must weigh the benefit of continuing her medication with the potential risks to the fetus. Until more information becomes available, GPs may ask pregnant patients whether they have an history of ADHD or if they intend to take medication in the perinatal stage.

A increasing number of studies have shown that women can continue their ADHD medication during pregnancy and breastfeeding. This has led to an increasing number of patients opt to do this and, in consultation with their doctor they have found that the benefits of keeping their current medication exceed any risk.

It is essential for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and strengthen coping mechanisms. This should be a multidisciplinary process with the GPs, obstetricians, and psychiatrists. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother as well as the child, monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.

Read More: https://writeablog.net/horserun14/the-complete-guide-to-managing-adhd-without-medication